CXCL8 and cancer: This panel achieved an area under the curve (AUC) of 0.86, significantly outperforming both IL-8 and MCP-1 when used individually (AUC = 0.80 or 0.76, all p < 0.05) to distinguish AA cancer patients from their healthy counterparts (Figure 2) (Table 3).